ABSTRACT The production of pro-inflammatory cytokines, such as interleukin-1 and tumor necrosis fac tor, is pivotal in the response to infection. However, overproduction of these cytokines might be detrimen tal. It has been suggested that (n-3) fatty acids sup press inflammation and ameliorate the course of infec tion by decreasing the production of pro-inflammatory cytokines. We here, review these effects, use of (n-3) fatty acids induced moderate clinical improvements in rheumatoid arthritis, psoriasis and colitis, but not in systemic lupus erythematosus. Data on critically ill burn or postoperative cancer patients are still inconclu sive. The (n-3) fatty acids markedly inhibited sterile inflammation in animal studies and improved survival in some experimental infections. T cell responses de creased in healthy volunteers but remained unchanged or increased in certain patient groups. The production of pro-inflammatory cytokines decreased in most hu man studies. The (n-3) fatty acids increased cytokine production capacity in mice. Differences in cytokineproducing cell types studied may account for these paradoxical responses in humans and mice. Although the increased cytokine production in mice is partly me diated by effects on prostaglandins, mechanisms of action in other species remain to be elucidated. The (n-3) fatty acids may be of moderate benefit in some chronic inflammatory diseases. Their therapeutic value and possible hazards in critically ill patients remain to be established. J. Nutr. 126: 1515-1533, 1996.
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The (n-3) polyunsaturated fatty acids have been in vestigated for use in the treatment of inflammatory diseases such as rheumatoid arthritis, psoriasis and ul cerative colitis. Presently, enterai tube feeding prepara tions containing relatively large amounts of (n-3) fatty acids are advanced for use in critically ill patients be cause of the presumed anti-inflammatory effects of these fatty acids (Cerra et al. 1991a and 1991b , Daly et al. 1992 , Gottschlich et al. 1990 ). Although the antiinflammatory effects of (n-3) fatty acids originally were attributed to changes in the production of prostaglan dins and leukotrienes , Lee et al. 1985 , Needleman et al. 1979 , recent studies have em phasized reduced production of cytokines as a possible mechanism (Billiar et al. 1988 ). Here, we review studies in humans and animals on the effects of (n-3) fatty acids on inflammation, resistance to infec tion, and cytokine production.
CYTOKINES AND INFLAMMATION
Cytokines are small proteins that are produced by a variety of cell types. They act on nearly every tissue and organ system. The cytokines interleukin-la (ILla),2 interleukin-IÃŸ (IL-1/3), tumor necrosis factor a (TNF) and interleukin-6 (IL-6) are often designated proinflammatory cytokines. They are mainly produced by the mononuclear phagocytic cells, including both cir culating monocytes and tissue macrophages. These cy tokines mediate the response of the host to inflamma tory stimuli. They induce fever, activation of B and T lymphocytes and endothelial cells, synthesis of acute phase proteins by the liver, and many other effects that are all part of the acute phase response (Table 1) (Dinarelio 1991) . The term "acute phase response" refers to a set of local and systemic neurologic, endocrine and metabolic changes through which the organism reacts to various stimuli, including infections, forms of sterile 1To whom correspondence should be addressed. 2Abbreviations used: IL-1, interleukin-1; IL-2, interleukin-2; IL-6, interleukin-6; LTB4, leukotriene B4; PGE2, prostaglandin E2; SLE, systemic lupus erythematosus; TNF, tumor necrosis factor. 1 -indicates that the effect is absent, + indicates a moderate effect, ++ indicates a strong effect.
2 The induction of these enzymes is pivotal in the formation of the so-called lipid mediators: prostaglandins, leukotrienes and plate let-activating factor. inflammation such as auto-immune disease, bleeding, injury (e.g., burn trauma and major surgery) and heavy exercise. The early events in the acute phase response are local and serve to check bleeding, to demarcate damaged tissues and to recruit cells for the subsequent reparative phase, which requires a systemic response. This second, systemic phase involves fever, anorexia, leukocytosis and metabolic changes that include an increased flow of amino acids from muscle to liver and a rearrangement of the pattern of protein synthesis in the liver: albumin production decreases and acute phase proteins such as fibrinogen, C-reactive protein and serum amyloid A are synthesized. Their appear ance in the plasma contributes to a well-known phe nomenon in inflammation: the elevated erythrocyte sedimentation rate.
Most of these changes are mediated by IL-1, TNF and IL-6. They can trigger cells to secrete other in flammatory mediators, including other cytokines such as the T lymphocyte products interferon gamma and interleukin-2 (IL-2) and lipid mediators such as prosta glandins, leukotrienes and platelet-activating factor. Elevated plasma concentrations of IL-6, TNF or IL-1 have been observed in patients with infections, endotoxemia, trauma or burns, but also in acute bouts of auto-immune disease such as rheumatoid arthritis or systemic lupus erythematosus (SLE)and in patients un dergoing organ transplant rejection (Dinarello 1992) . Increased IL-1 production by peripheral blood mononuclear cells and by colonie mononuclear cells has been reported in patients with active inflammatory bowel disease (Mahida et al. 1989, Mazlam and Hodgson 1992) .
Although production of pro-inflammatory cytokines is believed to benefit the host defense system, high concentrations of circulating pro-inflammatory cyto kines have been shown to correlate with poor outcome in severe disease states such as meningococcal septic shock (Waage et al. 1987 and , other forms of sep tic shock (Calandra et al. 1990 , Cannon et al. 1990 ) and cerebral malaria (Grau et al. 1989) . Elevated concentra tions of circulating or in vitro stimulated TNF and IL-1 were also reported in AIDS patients by several groups (Berman et al. 1987 , Lahdevirta et al. 1988 , Lepe-Zuniga et al. 1987 , Wright et al. 1988 , although not by others (Molina et al. 1989 and . Anti-cytokine strategies such as treatment with antibodies against TNF and treatment with the interleukin-l receptor antagonist were shown to reduce the severity of inflammation and to protect against mortality in animal models of septic shock, cerebral malaria and colitis (Comincili et al. 1990 , Grau et al. 1989 , Ohlsson et al. 1990 , Tracey et al. 1987 . From these observations, the concept of "lethal cytokinemia" has emerged, which implies that exaggerated cytokine production may be harmful or even lethal . It is also felt that the chronically elevated concentrations of cytokines in rheumatoid arthritis contribute to the perpetuating inflammation and are harmful to the pa tient (Eastgate et al. 1988, Firestein and Zvaifler 1992) . These observations have caused researchers to investi gate the possible benefits of reducing cytokine produc tion capacity through dietary intervention; of such in terventions, the use of very long chain essential fatty acids of the (n-3) family has received considerable at tention. Table 2 summarizes studies on the effects of dietary (n-3) fatty acids in inflammatory disease states in hu mans. Several investigators have developed tube feeding formulas with, among other modifications, (n-3) fatty acids as the major lipid source. These modified formulas have been investigated in bum patients (Gottschlich et al. 1990 ) and patients operated on for upper gastrointesti nal malignancies (Daly et al. 1992) . Both studies claimed reduction in infectious complications and in the length of hospital stay. However, both studies were not double blind, and disease severity or age were not evenly distrib uted between the study groups, hi a better controlled study by Moore et al. (1994) , trauma patients receiving a modified formula high in (n-3) fatty acids experienced fewer intra-abdominal abscesses and less multiple organ failure.
(n-3) FATTY ACIDS AND INFLAMMATION IN HUMANS
In placebo-controlled studies, patients with rheuma toid arthritis experienced small improvements of symptoms after ingestion of a fish oil concentrate for (Moore et al. 1987) . In one double-blind, crossover study using olive oil as the con trol, patients with moderately active SLE showed sig nificant clinical and serological benefits after 3 mo of fish oil consumption, but after 6 mo there was no differ ence between the treatment groups (Westberg and Tarkowski 1990) . Dietary fish oil supplementation had no effect on renal outcome in patients with SLE-associated nephritis (Clark et al. 1989) .
Taken together, these studies suggest some attenua tion of inflammation and thus of the acute phase re sponse by (n-3) fatty acids in humans. However, the rise in concentration of circulating acute phase pro teins induced by heavy exercise was increased in healthy volunteers after 3 wk of dietary supplementa tion with (n-3)fatty acids (Ernst et al. 1991) , suggesting increased rather than decreased formation of pro-in flammatory mediators after fish oil.
Thus, (n-3) fatty acids seem to have some beneficial effects in rheumatoid arthritis, psoriasis and ulcerative colitis, but only after prolonged ingestion, and labora tory indices of inflammation were not affected. The ef fects in bronchial asthma and SLEwere minimal to ab sent. Data on short-term treatment with (n-3)fatty acids in burn patients and in postoperative cancer patients are still inconclusive, although the results of one study in trauma patients are promising (Moore et al. 1994 ).
(n-3) FATTY ACIDS AND INFLAMMATION IN ANIMALS
Studies on the effects of dietary (n-3) fatty acids in experimental inflammations in animals are summa rized in Table 3 . Several studies have shown favorable effects of dietary fish oil supplementation in mouse models of SLE. These genetically susceptible mice spontaneously develop a SLE-like syndrome including glomerulonephritis, and the animals die before reach ing 1 y of age. Administration of fish oil convincingly retarded both the development of glomerulonephritis and premature death (Kelley et al. 1985 , Prickett et al. 1981 ). In a model of autoimmune arthritis in mice, dietary fish oil supplementation reduced the severity of joint inflammation (Leslie et al. 1985) . However, in similarly afflicted rats this effect was absent (Prickett et al. 1984) . In mice immunized with collagen, plasma concentrations of amyloid P component, an acute phase protein, were significantly reduced following a fish oil diet (Cathcart et al. 1987) . Inflammatory re sponses have been implicated in the etiology of noninsulin-dependent diabetes mellitus. In BHE rats, an ani mal model of noninsulin-dependent diabetes mellitus, longevity was shortened after a life-long fish oil diet (Berdanier et al. 1992) . However, the development of glucose intolerance and lipemia was delayed in these animals. Rats with immune complex-induced enteropathy developed significantly fewer severe inflam matory lesions after a fish oil diet than after a beef tallow diet (Bloch et al. 1989 ).Thus, most animal stud ies demonstrated a modulating effect of (n-3)fatty acids on inflammation.
Exogenous administration of IL-1 or TNF to experi mental animals induces an acute phase response, in cluding anorexia and fever (McCarthy et al. 1985 , Moldawer et al. 1988 , Tracey et al. 1988 .Apart from inter ference with cytokine production, dietary fish oil supplementation has been associated with attenuation of some of the responses to exogenously administered cytokines. In guinea pigs, the febrile response to an injection of recombinant murine IL-1 was attenuated after 6 wk of a fish oil-enriched diet compared with control diet (Pomposelli et al. 1989) . In rats, feeding fish oil for 6 wk attenuated the catabolic response to a combined infusion of IL-1 and TNF, as reflected by reduced whole-body leucine oxidation and increased net hepatic protein anabolism . Similarly, the anorexia induced by IL-1 administration was markedly decreased in rats fed fish oil for 6 wk (Hellerstein et al. 1989) , and thermogenic and pyrogenic responses to IL-1 were inhibited in rats after 4 to 9 wk of (n-3) fatty acid supplementation .These fish oil effects may be mediated by a reduced formation of prostaglandins, because both IL-1-induced fever and anorexia are attenuated by treatment with cyclooxygenase inhibitors (Hellerstein et al. 1989 , Okusawa et al. 1988 .
Thus, in several animal models of auto-immune dis ease and in experimentally induced acute phase re sponse, severity of inflammation seems to be favorably influenced by fish oils. In these animal studies, the effects of (n-3) fatty acids seem much stronger than in the clinical studies mentioned above. This difference could relate to the fact that most of these studies in volve feeding experimental diets to the animals before the appearance of any disease symptoms, whereas stud ies in humans have exclusively examined the activity of (n-3) fatty acids against a background of an existing clinical disease. Moreover, the relative amount of (n-3) fatty acids ingested in the animal studies is substan tially higher than in the human studies. response, thereby decreasing host resistance to infec tion? This question has been addressed in various ways. In several studies, human peripheral blood mononuclear cells from healthy volunteers were cultured in vitro. In these studies, T cell proliferation was inhib ited by the addition of (n-3) fatty acids to the culture medium (Calder et al. 1994 , Soyland et al. 1993 . In vivo studies on peripheral blood mononuclear cells after dietary supplementation with (n-3) fatty acids are summarized in Table 4 . Most studies in healthy volun teers show a decreased proliferative response of T lym phocytes to specific stimulants such as phytohemagglutinin or concanavalin A. The production capacity of T cell-derived cytokines and the T4/T8 ratio were found to be unchanged or depressed. On the other hand, studies in certain patient groups such as asthma pa tients and intensive care unit patients found a positive effect of dietary (n-3) fatty acids on T cell responses. One recent study even reported increased production of interferon-y following consumption of (n-3) fatty acids (Kemen et al. 1995) . At present it is unclear why T cell responses to dietary (n-3) fatty acids differ between healthy subjects and certain patient groups. Depressed T cell responses at baseline may play a role here. Wellcontrolled studies comparing different patient groups with healthy volunteers at baseline and after consump tion of dietary (n-3) fatty acids are certainly needed to clarify this issue.
Because decreased T cell functions may affect resis tance to cancer, the possible impact of dietary (n-3) fatty acids on carcinogenesis has been of concern. Epidemiological studies show that total fat intake is re lated to breast and colon cancer mortality (Kromhout 1990 , Wynder et al. 1986 ). Animal studies suggest that (n-6) fatty acids may have a tumor-promoting effect and that (n-3) fatty acids may exert an inhibitory effect on chemically induced mammary and colon tumorigenesis (Carroll and Braden 1984) . In a recent human study, low tissue levels of a-linolenic acid [18:3(n-3)J were found to be associated with early metastasis in breast cancer, suggesting a protective effect of (n-3) fatty acids (Bougnoux et al. 1994) . At present it is not clear whether the effects of dietary (n-3) fatty acids on carcinogenesis are related to their influence on T cell function.
The incidence of certain infectious diseases such as tuberculosis and diarrheal diseases has reportedly been increased in Eskimo populations. Because many socioeconomic and genetic factors contribute to the inci dence of infectious diseases, it is difficult to establish the contribution of dietary (n-3) fatty acids to this phe nomenon (Grzybowski and Dorken 1983) .
In animal studies, the effects of dietary (n-3) fatty acids on infections have been investigated with live pathogenic microorganisms or bacterial endotoxins, because Gram-negative bacteria such as Escherichia coli and meningococci are pathogenic largely because of the endotoxins that they release. In controlled stud ies, guinea pigs were protected against metabolic acidosis and death from endotoxin administration when they had been fed a fish oil-supplemented diet for 6 wk , Teo et al. 1991 , and the physi ological response to endotoxin infusion was favorably influenced when guinea pigs had been on total parenteral nutrition containing (n-3) fatty acids for only 3.5 d prior to administration of endotoxin (Table 5) . Two studies reported a negative effect of (n-3) fatty acids on outcome of experimental infection with live microorganisms. Chang et al. (1992) observed a decreased survival rate of fish oil-fed Swiss mice infected perorally with Salmonella typhimurium, and D' Ambola et al. (1991) reported diminished lung clearance of inspired Staphylococcus aureus in neona tal rabbits supplemented with high dose of fish oil or safflower oil. However, most studies indicate that the anti-inflammatory effect of dietary fish oil supplemen tation in animals in general does not lead to an in creased susceptibility to infection, and in several mod els of infection, outcome was even improved (Fig. 1 ) ( Table 5 ). This suggests that in certain cases (n-3) fatty acids will prevent the excessive production of cyto kines that, if unchecked, leads to death in septic ani mals.
(n-3) FATTY ACIDS AND CYTOKINE PRODUCTION

Methodological problems
Cytokine assays and their validity. Cytokines can exert their effects at extremely low concentrations (ng/ L), and under normal physiological conditions (e.g., in the absence of disease or trauma) circulating cytokines are often below the detection limits for most assay systems. Therefore, in many clinical studies with healthy human subjects cytokine-producing cells are isolated, cultured and then stimulated in vitro to ob tain detectable cytokine concentrations. Such studies tell us more about the cytokine production capacity of a given cell type in vitro than about changes in actual cytokine production occurring in vivo.
In most human studies, peripheral blood mononu clear cells are isolated using a density gradient. Subse quently, these cells are cultured for a short period (e.g., overnight) and stimulated to produce cytokines. In many animal studies, resident macrophages are iso lated from the peritoneal cavity or from organs such as the liver (Kupffer cells). Although culture principles for human and animal cells are basically the same, it can not be excluded that the differences in origin of these cells have some bearing on their cytokine production capacity in vitro.
Cytokines can be quantified by bioassay or by immunochemical methods. In bioassays, cell lines are used that are dependent on specific cytokines for growth. Such bioassays can detect cytokines at low concentra tions, but their specificity is poor. More recently, the availability of specific monoclonal and polyclonal anti bodies against various cytokines has enabled the devel opment of immunological detection methods such as ELISA and RIA. In body fluids, cytokines may be bound to specific proteins such as soluble receptors for TNF or to nonspecific ligands such as al macroglobulin and uromodulin. Such molecules may interfere with both bioassays and immunoassays. Receptor blocking mole cules such as the naturally occurring protein desig nated IL-1 receptor antagonist interfere with bioassays only (Dinarello 1991) . On the other hand, with ELISA and RIA one might be measuring biologically non-ac tive proteins. In general, the reproducibility and valid ity of immunoassays are superior to those of bioassays.
Design of dietary trials. Several human studies evaluating the influence of (n-3) fatty acids on cytokine production have compared baseline values with posttreatment values, without a concurrent control group. The contribution of aspecific fluctuations in cytokine production such as reduced stress through adaptation to the study protocol cannot be appreciated in such a before-and-after design. It also cannot be deduced from such studies whether the observed effects are specific for the type of polyunsaturated fatty acids employed. On the other hand, in placebo-controlled studies the type and amount of placebo fatty acids may be problem atic. In human studies, the dietary fat supplementation constitutes only a small percentage of the total energy intake, but in animal studies the fat supplement may account for 30% of total energy intake. When control groups receive such an amount of corn oil or safflower oil, both very rich in (n-6) fatty acids, this may well influence the production of prostaglandins and leukotrienes and thus may have some bearing on the resul tant cytokine production measured in these studies ). Ideally, in both human and ani mal supplementation studies, control groups should re ceive an isoenergetic quantity of fatty acids without disturbing the ratio of (n-3) to (n-6) fatty acids that was present in their diets before the start of the study. Table 6 presents an overview of human studies con cerning the effects of (n-3) fatty acids on cytokine pro duction. In several studies peripheral blood mononuclear cells were isolated and profound decreases in ex vivo production of IL-1, TNF and IL-6 were noted . Unfortunately, these studies did not employ a placebo group taking an isoenergetic amount of a fatty acid supplement low in polyunsaturated fatty acids and a (n-6) to (n-3) ratio similar to that in the subjects' normal diet. Meydani et al. (1993) reported on cytokine production capacity in 22 subjects before and after 24 wk of a low fat diet. The diets were either low or high in (n-3) fatty acids, which were provided as natural food components. Ex vivo production of IL-1/3, TNF and IL-6 by isolated pe ripheral blood mononuclear cells fell significantly in the high (n-3) fatty acids group. In contrast, IL-1/3 and TNF production increased in the low (n-3) fatty acids group. The two groups were not studied simultane ously, as the authors state, to avoid seasonal differ ences. Molvig et al. (1991) studied ex vivo cytokine production after low and high dose dietary fish oil sup plementations in healthy young men and in subjects with diabetes. Control subjects took an isoenergetic amount of a triglycÃ©rideblend. After 7 wk of oil supple mentation, concentrations of secreted IL-iÃŸand of se creted and cell-associated TNF were not different be tween groups. Only cell-associated IL-1/3 was decreased in the fish oil group. This finding is surprising, because it is IL-la that remains cell associated whereas IL-1/3 is mainly released into the culture medium . In contrast with the findings of Endres et al. (1989) no differences in ex vivo cytokine produc tion were noted between the groups 10 wk after cessa tion of the diet. Even though the authors had an appro priate control group, the conclusions from this study should be viewed with caution. This is because the authors do not present the values from the start of the study. Such a design (i.e., repeated measures) would have greatly strengthened this study, because it can help control for inherent intrasubject variation. In other words, it is the changes in cytokine production that (n-3) fatty acids cause that is really most important and not the absolute amount of cytokine made by each subject. In a study of rheumatoid arthritis patients, IL-1 fell over time in all groups, including the control group taking olive oil (Kremer et al. 1990 ). studied young volunteers before and after dietary supplementation with fish oil during 6 to 8 wk. A con current control group did not alter their usual diets. Using a somewhat different method of cytokine mea surement (whole blood culture), they found that ex vivo production of IL-1 and IL-6 was suppressed after fish oil supplementation. However, production of TNF was not significantly altered. Interestingly, these inves tigators found an attenuation of the inflammatory re sponse to an intramuscular injection of typhoid vaccine in the fish oil group. Recently, Cannon et al. (1995) found no differences in ex vivo stimulated IL-IÃŸpro duction in older subjects after 4 mo of dietary fish oil supplementation compared with controls taking a pla cebo of neutral fat composition. Again, in this study no conclusions can be drawn about changes in cytokine concentrations induced by fish oil, and possible effects may be masked by intersubject variations. Espersen et al. (1992) reported a reduction in plasma IL-1/3 concen trations after fish oil supplementation in rheumatoid arthritis patients that did not occur in the concurrent control group.
The effects of (n-3) fatty acids on cytokine production in humans
In the Endres-Meydani peripheral blood mononuclear cells were cultured in the presence of autologous serum or plasma, whereas in Cannon's and Molvig's studies (Cannon et al. 1995 , Molvig et al. 1991 , pooled normal human serum was used. Theoretically, the fatty acids present in the autologous serum could have influenced the in vitro cytokine production. However, preincubation of human peripheral blood mononuclear cells with eicosapentanoic acid resulted only in a marginal sup pression of IL-1/0 synthesis, whereas TNF synthesis was not affected at all .
Whether (n-3) fatty acids reduce inflammation in cer tain human disease states through inhibition of cytokine production remains speculative, but most studies, con trolled or not, report a decrease in one or more pro-in flammatory cytokines after dietary (n-3) fatty acids.
(n-3) fatty acids and cytokine production in animals
Animal studies concerning the production of cyto kines after dietary (n-3) polyunsaturated fatty acid sup plementation are summarized in Table 7 .
Rats. Billiar et al. (1988) reported decreased bioactivity of IL-1 and TNF produced in vitro by liver macro phages of rats after 6 wk of dietary supplementation with fish oil. Control animals were fed an equal amount of corn oil. However, animals receiving safflower oil, which is rich in (n-6) polyunsaturated fatty acids, showed a decrease in IL-1 and TNF production similar to that in animals fed fish oil. This latter find ing is difficult to interpret, because in both corn oil and safflower oil the predominant fatty acid is linoleic acid. Grimm et al. (1994) also found decreased produc tion of IL-6 and TNF in peripheral blood mononuclear cells of rats fed (n-3) fatty acids for 4 d.
In contrast to these findings, Turek et al. (1991) re ported increased TNF production capacity of resident peritoneal macrophages in rats fed linseed oil for 30 d. Linseed oil is rich in a-linolenic acid, an (n-3) fatty acid and precursor of eicosapentanoic acid. Control animals received com oil. Interestingly, when the peritoneal cells were elicited by the in vivo administration of complete Freund's adjuvant, the differences in TNF production in the two dietary groups were no longer apparent.
Mice. There seems to be a contrast between the ef fects of (n-3) fatty acids on cytokine production in mice and in the other species studied. Watanabe et al. (1991) studied the effects of feeding a-linolenic acid on TNF production by murine peritoneal macrophages. Control animals received safflower oil, rich in linoleic acid and low in (n-3) fatty acids. Diets were given for 4 to 5 wk. Endotoxin-stimulated TNF production by peritoneal macrophages was significantly higher in the a-linole nic acid group than in the control group. The authors also reported a considerably higher serum TNF activity in the a-linolenic acid group after in vivo injection of endotoxin. Lokesh et al. (1990) studied the synthesis of IL-1 and TNF by mouse peritoneal macrophages after 4 wk of dietary supplementation with fish oil, corn oil or olive oil. An IL-1 bioassay was performed on the supernatants of cultured peritoneal macrophages stimulated with endotoxin after lysis of the cells, and thus proba bly reflected mainly IL-la. The TNF bioactivity was measured in the supernatants of these macrophages. Both IL-1 and TNF were markedly increased in the mice fed fish oil compared with control animals. Simi larly, found enhanced in vitro stimulated TNF production by resident perito neal macrophages in mice that had been fed an (n-3) fatty acid-supplemented diet for 5 wk. Enlarging on these observations, the same group studied the kinetics of TNF release by in vitro-stimulated murine resident peritoneal macrophages after 4 wk of fish oil or control diet . Although total TNF pro duction was again increased, the kinetics of maximum TNF production appeared not to be affected by the diets. These findings were basically confirmed by Somers and Erickson (1994) .
Our group has studied ex vivo production of IL-1 and TNF by peritoneal cells from mice fed fish oil, corn oil or palm oil for 6 wk (Blok et al. 1992 ). Interleukin-la, IL-IÃŸand TNF were measured by specific immunoassays. Interleukin-la and TNF production by peritoneal cells were significantly higher in the fish oil-fed ani mals than in controls (Fig. 2) . Ertel et al. (1993) found increased IL-1/? release by peritoneal macrophages of mice following experimental hemorrhagic shock.
Thus, the effects of dietary (n-3) fatty acids on cyto kine production in mice are opposite to those in hu mans: in mice, several controlled studies have indepen dently shown increased cytokine production after (n-3) fatty acid supplementation, whereas in humans de creased cytokine production was found. As can be seen in Tables 6 and 7 , human studies have exclusively used >M"I *jTO4jWÃ-o*jÃ-Â« Q .â€" rÃ-w^j it rOÃ ¶e Ã ¶s 'S "^'S Ã‹u 'S E jS^Â»e 'g 6 Ã¼j -gS
'f ""* aÂ¿ peripheral blood cells, whereas most animal studies (rats and mice) used isolated tissue macrophages. Thus, as pointed out before, differences in origin of the cell types used to study cytokine production may account for the paradoxical responses to (n-3) fatty acids in hu mans and animals. This hypothesis is supported by the only animal study using peripheral blood mononuclear cells, which found decreased IL-6 and TNF production (Grimm et al. 1994) . To clarify this issue, studies are needed to evaluate the influence of dietary (n-3) fatty acids on cytokine production in isolated peripheral blood mononuclear cells and tissue macrophages si multaneously.
As in the human studies, there is no evidence that the alleviation of inflammation by (n-3) fatty acids in animal studies is mediated by alterations in cytokine production. Studies employing (n-3) fatty acids simul taneously with control measures such as agonists or antagonists of cytokines have not been performed.
POSSIBLE MECHANISMS OF THE MODULATION OF CYTOKINE PRODUCTION BY DIETARY (n-3) FATTY ACID INTAKE
At present, the mechanisms by which dietary (n-3) fatty acids modulate cytokine production have not been elucidated. Until recently, the alleviation of in flammation after the ingestion of (n-3) fatty acids has mainly been attributed to a reduced production by leu kocytes of the eicosanoids prostaglandin E2 (PGE2) and leukotriene B4(LTB4). Inflammatory agonists stimulate eicosanoid synthesis by enhancing the release of arachidonic acid from the intracellular phospholipid pool through activation of phospholipases.
Subsequently, the free arachidonic acid is metabolized into prostaglandins and leukotrienes by the enzymes cyclooxygenase and lipoxygenase, respectively. Eicosapentanoic acid, one of the (n-3) polyunsaturated fatty acids found in high concentrations in fish oil, is rapidly incorpo rated into cell membrane phospholipids, where it re places arachidonic acid as a substrate and is converted into the biologically less active prostaglandin E3 (PGE3 ) and leukotriene B5 (LTBS) (Lee et al. 1985) . Moreover, (n-3) fatty acids have been shown to be poorly metabo lized by cyclooxygenase, thereby reducing the total pro duction of eicosanoids (Lee et al. 1985) .
Prostaglandins. Changes in the production of the eicosanoids PGE2 and LTB4 have been postulated as mechanisms of altered cytokine production after di etary fatty acid supplementation.
In vitro addition of PGE2 to human peripheral blood mononuclear cells in hibits TNF production, probably by increasing intracel lular cyclic AMP , Renz et al. 1988 . Initially, the in vitro production of IL-1 has also been reported to be under inhibitory control of PGE2, but FIGURE 2 Cytokine production capacity of murine peri toneal cells. Swiss mice were fed fish oil, palm oil or corn oil for 6 wk. Peritoneal cells were isolated and cultured with (dark bars) or without endotoxin (light bars). Tumor necrosis factor (TNF ) was measured in the culture medium; interleukin-la (IL-la) was measured after lysis of the cells. Both TNF and IL-la were significantly higher in the fish oil-fed mice than in those fed corn oil or palm oil (P < 0.05). Reproduced with permission from Blok et al. (1992) . LPS = lipopolysaccharide.
since the availability of specific IL-1 assays it has be come clear that in vitro IL-1 secretion is not inhibited by PGE2 , Scales et al. 1989 . In vivo inhibition of PGE2 production by administration of a cyclooxygenase inhibitor has been reported to increase circulating concentrations of IL-6 and TNF during acute endotoxinemia in humans (Spinas et al. 1991) . Because PGE2 concentrations are decreased following consumption of an (n-3) fatty acid-rich diet, it is un likely that prostaglandins play an important role in the decreased TNF production observed in humans and some other species. In mice, however, decreased PGE2 production could account for the observed increases in TNF after (n-3) fatty acids. Two groups reported that the increase in TNF production by peritoneal macro phages from mice fed fish oil or control diets could be substantially reduced by treating these cells with PGE2 Kinsella 1991, Hubbard et al. 1991) . However, TNF production capacity was still elevated in the mice fed (n-3) fatty acids compared with controls. Hardardottir and Kinsella 1991) also showed that after the abolition of PGE2 production in all dietary groups by indomethacin, peritoneal macrophages of fish oilfed mice still produced significantly more TNF. This indicates that in mice, reduced PGE2 production is not the only mechanism responsible for the increased TNF production.
Leukotrienes. As suggested by Endres et al. (1989) , a fish oil-induced decrease in the synthesis of lipoxygenation products of arachidonic acid may account for inhibition of cytokine production. However, studies on the effect of leukotrienes on IL-1 production have shown divergent results. Leukotriene B4 was reported to enhance lipopolysaccharide-induced IL-1 production by human monocytes in vitro (Rola-Pleszczynski and Lemaire 1985), but specific leukotriene inhibitors failed to reduce IL-1 production by human and mouse mononuclear cells at concentrations that completely inhibited leukotriene synthesis (Hoffman et al. 1991 , Parkar et al. 1990 ). In mice, treatment with lipoxygenase inhibitors suppressed the circulating TNF concen trations after endotoxin injection as well as the ex vivo TNF production by peritoneal macrophages (Schade et al. 1989) . Endres et al. (1989) suggested that the pro found decrease in IL-1 and TNF production at 10 wk after cessation of the fish oil diet might have been due to reduced production of LTB4. However, others re ported complete restoration of LTB4 formation by neutrophils and peripheral blood mononuclear cells within 8 wk after cessation of a similar diet (Tulleken et al. 1989) . These data suggest that reduced synthesis of leu kotrienes is unlikely to cause the reduced cytokine pro duction after (n-3) fatty acid administration.
Dual inhibition. Studies with agents that inhibit both the lipoxygenase-and cyclooxygenase-mediated metabolism of arachidonic acid are of interest, because dietary (n-3) fatty acid supplementation results in a similar reduction of both prostaglandins and leuko trienes. One of these agents, tebufelone, enhanced IL-1 and TNF synthesis by human peripheral blood mononuclear cells at concentrations that suppressed leuko triene formation (Sirko et al. 1991) . Another dual cyclooxygenase/lipoxygenase inhibitor, SK&F 86002, protected mice from endotoxin-induced mortality and reduced circulating TNF concentrations (Badger et al. 1989) . Differences in species studied may account for these divergent findings. However, because dual cyclooxygenas/lipoxygenase inhibitors seem to in crease cytokine production in human cells and de crease cytokine production in mice, these observations are opposite to the observed decrease in cytokine pro duction in humans and the increased cytokine produc tion in mice induced by (n-3) fatty acids. Thus, these observations again argue against reduced eicosanoid synthesis as an explanation for these effects.
Vitamin E and cytokine production. Fish oil con centrates used in clinical and experimental studies are enriched in vitamin E to prevent lipid peroxidation. The effects of dietary fish oil supplementation on cyto kine production could thus theoretically be due to the vitamin E rather than to the (n-3) fatty acids. Meydani et al. (1989) studied this issue in a group of elderly human volunteers who consumed 800 iu of all-rac-a-tocopheryl acetate daily for 30 d. Endotoxinstimulated IL-1 bioactivity was not affected by this vi tamin E supplementation. Cannon et al. (1991) studied male volunteers who supplemented their diets with 800 iu of all-rac-a-tocopherol daily for 48 d. After a session of heavy exercise, IL-1/3 production capacity rose in subjects receiving placebo but not in vitamin Esupplemented subjects. The TNF production capacity was not affected by vitamin E; IL-6 production capacity was, however, significantly reduced in the vitamin E group. These studies show that vitamin E supplemen tation in itself may exert sortie influence on cytokine production. However, the amount of vitamin E em ployed in these studies is much higher than that in gested in the fish oil studies (800 iu vs. approximately 20 lU/d). Therefore it remains questionable whether vitamin E may account for the changes observed after dietary fish oil supplementation.
Modulation of signal transduction. Some studies have addressed the question whether (n-3) fatty acids alter intracellular signal transduction pathways in volved in the synthesis of cytokines. In mice, 10 d of dietary supplementation with (n-3) fatty acids signifi cantly increased the diacylglycerol concentration in concanavalin A-stimulated splenocytes (Fowler et al. 1993) . The (n-3) fatty acids seemed to modulate the activities of protein kinase C and cAMP-dependent pro tein kinases in a lymphoma cell line (Speizer et al. 1991) . It is thus conceivable that (n-3 (fatty acids induce changes in the concentrations or activities of intracel lular factors involved in cytokine production. Clearly, these data need to be confirmed and related to changes in cytokine production.
CONCLUSIONS
Anti-inflammatory effects of dietary fish oil supple mentation have been observed in clinical studies of rheumatoid arthritis, psoriasis and ulcerative colitis. The effects of (n-3) fatty acids seem to be stronger in animal models of chronic inflammation than in the clinical studies. This may relate to the early institution of supplementation and the very high intake of (n-3) fatty acids in the animal studies. In humans, the antiinflammatory potential of fish oil seems to be limited. Studies in critically ill burn or postoperative cancer patients yielded inconclusive results, but one study in trauma patients is promising. It is unclear whether the anti-inflammatory effects of fish oil in humans are me diated through a reduction in cytokine production or through other mechanisms such as reduced production of lipid mediators; studies in humans have reported impressive reductions in cytokine production capacity, although not all studies were properly controlled. The data from animal studies show the opposite: increased IL-1 and TNF production capacity after (n-3) fatty acid supplementation. Differences in origin of cytokine-producing cells may account for this paradoxical response to (n-3) fatty acids in humans and mice.
Interference with the negative feedback of prostaglandins on TNF production partly accounts for the increased TNF production after (n-3) fatty acid supple mentation in mice. The mechanism of action of (n-3) fatty acids on IL-1 production in mice and on cytokine production in other species remains to be elucidated.
The issue whether dietary (n-3) fatty acids decrease host resistance to infections is still unresolved. T cell responses increased in certain patient groups after (n-3) fatty acid consumption but decreased in healthy sub jects. Baseline T cell activation may play a role here. Some animal studies suggest a beneficial effect of (n-3) fatty acids on outcome of infections, whereas others report an adverse or no effect. Thus, at present there is no firm scientific evidence that enterai feedings en riched in (n-3)fatty acids are of benefit in the treatment of critically ill patients. Future research in this field may be directed in several ways. First, studies are needed to relate the contributions of the various lipid mediators and the intracellular signal transduction sys tems to the observed effects of (n-3) fatty acids on in flammation and on cytokine production. Second, differ ent cytokine-producing cell types should be studied si multaneously in one species to unravel the paradoxical responses to dietary (n-3) fatty acids in humans and mice. Third, in view of the preliminary studies already performed and given the increasing number of immunocompromised patients in our hospitals and intensive care units, well-designed studies are needed to assess the potential benefit of dietary (n-3) fatty acids in this group of patients.
